Clinical Trial Update: Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Update on a Phase 1 trial of cyclosporine A in combination with nab-paclitaxel for metastatic breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cyclosporine A (cyclosporine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Northwestern University | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED